Patents Assigned to PreLem S.A.
  • Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding
    Publication number: 20100190758
    Abstract: Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days.
    Type: Application
    Filed: April 18, 2008
    Publication date: July 29, 2010
    Applicant: PreLem S.A.
    Inventors: Bartholomeus C.J.M. Fauser, Ernest Loumaye